• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用脑脊液基本参数和MRZ反应的联合分析鉴别神经结节病与多发性硬化症。

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction.

作者信息

Vlad Benjamin, Neidhart Stephan, Hilty Marc, Ziegler Mario, Jelcic Ilijas

机构信息

Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Neuroimmunology and Multiple Sclerosis Research Section, Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

出版信息

Front Neurol. 2023 Mar 24;14:1135392. doi: 10.3389/fneur.2023.1135392. eCollection 2023.

DOI:10.3389/fneur.2023.1135392
PMID:37034091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10080049/
Abstract

BACKGROUND

Neurosarcodosis is one of the most frequent differential diagnoses of multiple sclerosis (MS) and requires central nervous system (CNS) biopsy to establish definite diagnosis according to the latest consensus diagnostic criteria. We here analyzed diagnostic values of basic cerebrospinal fluid (CSF) parameters to distinguish neurosarcoidosis from MS without CNS biopsy.

METHODS

We retrospectively assessed clinical, radiological and laboratory data of 27 patients with neurosarcoidosis treated at our center and compared following CSF parameters with those of 138 patients with relapsing-remitting MS: CSF white cell count (WCC), CSF/serum albumin quotient (Q), intrathecal production of immunoglobulins including oligoclonal bands (OCB), MRZ reaction, defined as a polyspecific intrathecal production of IgG reactive against ≥2 of 3 the viruses measles (M), rubella (R), and zoster (Z) virus, and CSF lactate levels. Additional inflammatory biomarkers in serum and/or CSF such as neopterin, soluble interleukin-2 receptor (sIL-2R) and C-reactive protein (CRP) were assessed.

RESULTS

There was no significant difference in the frequency of CSF pleocytosis, but a CSF WCC > 30/μl was more frequent in patients with neurosarcoidosis. Compared to MS, patients with neurosarcoidosis showed more frequently an increased Q and CSF lactate levels as well as increased serum and CSF levels of sIL-2R, but a lower frequency of intrathecal IgG synthesis and positive MRZ reaction. Positive likelihood ratio (PLR) of single CSF parameters indicating neurosarcoidosis was highest, if (a) CSF WCC was >30/μl (PLR 7.2), (b) Q was >10 × 10 (PLR 66.4), (c) CSF-specific OCB were absent (PLR 11.5), (d) CSF lactate was elevated (PLR 23.0) or (e) sIL-2R was elevated (PLR>8.0). The combination of (a) one of three following basic CSF parameters, i.e., (a.1.) CSF WCC >30/ul, or (a.2.) Q >10 × 10, or (a.3.) absence of CSF-specific OCB, and (b) absence of positive MRZ reaction showed the best diagnostic accuracy (sensitivity and specificity each >92%; PLR 12.8 and NLR 0.08).

CONCLUSION

Combined evaluation of basic CSF parameters and MRZ reaction is powerful in differentiating neurosarcoidosis from MS, with moderate to severe pleocytosis and Q elevation and absence of intrathecal IgG synthesis as useful rule-in parameters and positive MRZ reaction as a rule-out parameter for neurosarcoidosis.

摘要

背景

神经结节病是多发性硬化症(MS)最常见的鉴别诊断之一,根据最新的共识诊断标准,需要进行中枢神经系统(CNS)活检以确诊。我们在此分析了基本脑脊液(CSF)参数在不进行CNS活检的情况下区分神经结节病与MS的诊断价值。

方法

我们回顾性评估了在我们中心接受治疗的27例神经结节病患者的临床、放射学和实验室数据,并将以下CSF参数与138例复发缓解型MS患者的参数进行了比较:CSF白细胞计数(WCC)、CSF/血清白蛋白商(Q)、鞘内免疫球蛋白产生(包括寡克隆带(OCB))、MRZ反应(定义为针对麻疹(M)、风疹(R)和带状疱疹(Z)病毒中的≥2种病毒产生多特异性鞘内IgG反应)以及CSF乳酸水平。还评估了血清和/或CSF中的其他炎症生物标志物,如新蝶呤、可溶性白细胞介素-2受体(sIL-2R)和C反应蛋白(CRP)。

结果

CSF细胞增多的频率无显著差异,但神经结节病患者中CSF WCC>30/μl更为常见。与MS相比,神经结节病患者的Q和CSF乳酸水平升高以及血清和CSF中sIL-2R水平升高更为常见,但鞘内IgG合成频率和MRZ反应阳性率较低。单个CSF参数提示神经结节病的阳性似然比(PLR)最高的情况为:(a)CSF WCC>30/μl(PLR 7.2),(b)Q>10×10(PLR 66.4),(c)无CSF特异性OCB(PLR 11.5),(d)CSF乳酸升高(PLR 23.0)或(e)sIL-2R升高(PLR>8.0)。以下三个基本CSF参数中的一个,即(a.1.)CSF WCC>30/μl,或(a.2.)Q>10×10,或(a.3.)无CSF特异性OCB,与(b)无MRZ反应阳性相结合,显示出最佳的诊断准确性(敏感性和特异性均>92%;PLR 12.8和NLR 0.08)。

结论

基本CSF参数和MRZ反应的联合评估在区分神经结节病与MS方面具有强大作用,中度至重度细胞增多、Q升高以及无鞘内IgG合成作为有用的纳入参数,而MRZ反应阳性作为神经结节病的排除参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53df/10080049/1f5e58401a48/fneur-14-1135392-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53df/10080049/8312ef5e133f/fneur-14-1135392-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53df/10080049/6c1e2c1f334b/fneur-14-1135392-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53df/10080049/1f5e58401a48/fneur-14-1135392-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53df/10080049/8312ef5e133f/fneur-14-1135392-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53df/10080049/6c1e2c1f334b/fneur-14-1135392-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53df/10080049/1f5e58401a48/fneur-14-1135392-g0003.jpg

相似文献

1
Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction.利用脑脊液基本参数和MRZ反应的联合分析鉴别神经结节病与多发性硬化症。
Front Neurol. 2023 Mar 24;14:1135392. doi: 10.3389/fneur.2023.1135392. eCollection 2023.
2
Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis.基本 CSF 参数和 MRZ 反应有助于区分 MO G 抗体相关性自身免疫性疾病与多发性硬化症。
Front Immunol. 2023 Sep 6;14:1237149. doi: 10.3389/fimmu.2023.1237149. eCollection 2023.
3
Oligoclonal restriction of antiviral immunoreaction in oligoclonal band-negative MS patients.寡克隆带阴性多发性硬化症患者抗病毒免疫反应的寡克隆限制
Acta Neurol Scand. 2015 Jun;131(6):381-8. doi: 10.1111/ane.12350. Epub 2014 Nov 17.
4
Intrathecal immune reactivity against Measles-, Rubella-, and Varicella Zoster viruses is associated with cerebrospinal fluid inflammation in multiple sclerosis.鞘内针对麻疹病毒、风疹病毒和水痘带状疱疹病毒的免疫反应与多发性硬化症的脑脊液炎症有关。
Mult Scler. 2024 Nov;30(13):1598-1608. doi: 10.1177/13524585241279645. Epub 2024 Oct 8.
5
Analysis of soluble interleukin-2 receptor as CSF biomarker for neurosarcoidosis.分析可溶性白细胞介素-2 受体作为神经结节病的 CSF 生物标志物。
Neurol Neuroimmunol Neuroinflamm. 2020 May 11;7(4). doi: 10.1212/NXI.0000000000000725. Print 2020 Jul.
6
Association of cerebrospinal fluid kappa free light chains with the intrathecal polyspecific antiviral immune response in multiple sclerosis.脑脊液κ 游离轻链与多发性硬化症鞘内多特异性抗病毒免疫反应的关系。
Clin Chim Acta. 2019 Nov;498:148-153. doi: 10.1016/j.cca.2019.08.016. Epub 2019 Aug 19.
7
Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.模式 II 和模式 III 多发性硬化症是与模式 I 多发性硬化症不同的实体:来自脑脊液分析的证据。
J Neuroinflammation. 2017 Aug 29;14(1):171. doi: 10.1186/s12974-017-0929-z.
8
The intrathecal polyspecific antiviral immune response (MRZ reaction): A potential cerebrospinal fluid marker for multiple sclerosis diagnosis.鞘内多特异性抗病毒免疫反应 (MRZ 反应):多发性硬化症诊断的潜在脑脊液标志物。
J Neuroimmunol. 2018 Aug 15;321:66-71. doi: 10.1016/j.jneuroim.2018.05.015. Epub 2018 May 28.
9
Clinical associations and characteristics of the polyspecific intrathecal immune response in elderly patients with non-multiple sclerosis chronic autoimmune-inflammatory neurological diseases - a retrospective cross-sectional study.老年非多发性硬化慢性自身免疫性炎症性神经系统疾病患者鞘内多特异性免疫反应的临床关联及特征——一项回顾性横断面研究
Front Neurol. 2023 Jun 15;14:1193015. doi: 10.3389/fneur.2023.1193015. eCollection 2023.
10
Cerebrospinal Fluid Findings in 541 Patients With Clinically Isolated Syndrome and Multiple Sclerosis: A Monocentric Study.541 例临床孤立综合征和多发性硬化患者的脑脊液检查结果:一项单中心研究。
Front Immunol. 2021 Jun 17;12:675307. doi: 10.3389/fimmu.2021.675307. eCollection 2021.

引用本文的文献

1
Neurosarcoidosis: Current Perspectives on Diagnosis, Management, and Future Directions.神经结节病:关于诊断、管理及未来方向的当前观点
Cureus. 2024 Sep 11;16(9):e69208. doi: 10.7759/cureus.69208. eCollection 2024 Sep.
2
[Position paper of the Austrian Society for Rheumatology and the Austrian Society for Pneumology on the diagnosis and treatment of sarcoidosis 2024].[奥地利风湿病学会和奥地利肺病学会关于结节病诊断与治疗的立场文件(2024年)]
Wien Klin Wochenschr. 2024 Oct;136(Suppl 17):669-687. doi: 10.1007/s00508-024-02444-z. Epub 2024 Oct 9.
3
Intrathecal immune reactivity against Measles-, Rubella-, and Varicella Zoster viruses is associated with cerebrospinal fluid inflammation in multiple sclerosis.

本文引用的文献

1
Sarcoidosis and obsessive-compulsive symptoms.结节病与强迫症状。
J Neuroimmunol. 2022 Dec 15;373:577989. doi: 10.1016/j.jneuroim.2022.577989. Epub 2022 Oct 17.
2
Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to "overlap" cases.从多发性硬化症中鉴别中枢神经系统神经结节病及“重叠”病例的处理方法。
J Neuroimmunol. 2022 Aug 15;369:577904. doi: 10.1016/j.jneuroim.2022.577904. Epub 2022 Jun 2.
3
Neurosarcoidosis: Pathophysiology, Diagnosis, and Treatment.神经结节病:病理生理学、诊断和治疗。
鞘内针对麻疹病毒、风疹病毒和水痘带状疱疹病毒的免疫反应与多发性硬化症的脑脊液炎症有关。
Mult Scler. 2024 Nov;30(13):1598-1608. doi: 10.1177/13524585241279645. Epub 2024 Oct 8.
4
Diagnostic value of soluble Interleukin-2 receptor in patients suffering neurosarcoidosis: A systematic review.可溶性白细胞介素-2受体在神经结节病患者中的诊断价值:一项系统评价。
J Cent Nerv Syst Dis. 2024 Aug 26;16:11795735241274186. doi: 10.1177/11795735241274186. eCollection 2024.
5
Cerebral lesions sites in neurosarcoidosis: a lesion mapping study.神经结节病性脑损害部位:病灶定位研究。
J Neurol. 2023 Nov;270(11):5392-5397. doi: 10.1007/s00415-023-11863-3. Epub 2023 Jul 12.
Neurol Neuroimmunol Neuroinflamm. 2021 Oct 4;8(6). doi: 10.1212/NXI.0000000000001084. Print 2021 Nov.
4
Neurosarcoidosis mimicry of MS: Clues from cases with CNS tissue diagnosis.神经结节病样多发性硬化症:来自中枢神经系统组织诊断病例的线索。
J Neurol Sci. 2021 Oct 15;429:117621. doi: 10.1016/j.jns.2021.117621. Epub 2021 Aug 23.
5
Clinical characterization and outcomes of 85 patients with neurosarcoidosis.85 例神经结节病患者的临床特征和转归。
Sci Rep. 2021 Jul 2;11(1):13735. doi: 10.1038/s41598-021-92967-6.
6
2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis.2021 年 MAGNIMS-CMSC-NAIMS 关于多发性硬化症患者使用 MRI 的共识建议。
Lancet Neurol. 2021 Aug;20(8):653-670. doi: 10.1016/S1474-4422(21)00095-8. Epub 2021 Jun 14.
7
Likelihood Ratio Approach and Clinical Interpretation of Laboratory Tests.实验室检查的似然比方法及临床解读
Front Immunol. 2021 Apr 16;12:655262. doi: 10.3389/fimmu.2021.655262. eCollection 2021.
8
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.全球多发性硬化症患病率上升:第三版多发性硬化症图谱的见解。
Mult Scler. 2020 Dec;26(14):1816-1821. doi: 10.1177/1352458520970841. Epub 2020 Nov 11.
9
Biomarkers in the Diagnosis and Prognosis of Sarcoidosis: Current Use and Future Prospects.结节病的诊断和预后的生物标志物:当前的应用和未来的前景。
Front Immunol. 2020 Jul 14;11:1443. doi: 10.3389/fimmu.2020.01443. eCollection 2020.
10
Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide.视神经脊髓炎谱系障碍的流行病学及其在全球的患病率和发病率
Front Neurol. 2020 Jun 26;11:501. doi: 10.3389/fneur.2020.00501. eCollection 2020.